Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.98 in the prior trading day, Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $0.92, down -6.38%. In other words, the price has decreased by -$6.38 from its previous closing price. On the day, 1.0 million shares were traded. KPTI stock price reached its highest trading level at $0.9986 during the session, while it also had its lowest trading level at $0.916.
Ratios:
Our goal is to gain a better understanding of KPTI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.04.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 05 ’24 when Paulson Richard A. sold 3,616 shares for $0.85 per share. The transaction valued at 3,077 led to the insider holds 1,146,489 shares of the business.
PAKIANATHAN DEEPIKA sold 231,548 shares of KPTI for $220,133 on Jun 07 ’24. The Director now owns 0 shares after completing the transaction at $0.95 per share. On Jun 06 ’24, another insider, PAKIANATHAN DEEPIKA, who serves as the Director of the company, sold 118,452 shares for $0.98 each. As a result, the insider received 116,415 and left with 2,240 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 114335184 and an Enterprise Value of 268336160. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.81. Its current Enterprise Value per Revenue stands at 1.91 whereas that against EBITDA is -2.032.
Stock Price History:
Over the past 52 weeks, KPTI has reached a high of $1.95, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -7.76%, while the 200-Day Moving Average is calculated to be -12.34%.
Shares Statistics:
The stock has traded on average 1.44M shares per day over the past 3-months and 1111030 shares per day over the last 10 days, according to various share statistics. A total of 114.92M shares are outstanding, with a floating share count of 110.07M. Insiders hold about 11.68% of the company’s shares, while institutions hold 60.25% stake in the company. Shares short for KPTI as of 1719532800 were 21644093 with a Short Ratio of 15.02, compared to 1717113600 on 20146797. Therefore, it implies a Short% of Shares Outstanding of 21644093 and a Short% of Float of 17.709999.
